ARCHIVES

In Brief: LENORA JOHNSON Was Named Director Of Health Education, Communications, And Science Policy at the National Heart Lung and Blood Institute

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

April 24, 2009

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013

NCI To Proceed With Guidelines Unless Board Strongly Disagree

May 9, 1980

The Cancer Letter Wins Journalism Award

April 1, 2011